Abstract This paper presents a methodology to integrate cost–benefit analysis and SAM-CGE-based impact evaluation. While the two types of have developed in parallel without clear connection, there is growing consensus that approaches should be integrated for complex investment projects, since their economic evaluation cannot rely solely on partial equilibrium assumptions (CB) analysis. Unlike C...

This chapter gives an overview of benefit-cost analysis (BCA) and similar evaluation tools, such as cost-effectiveness analysis and technology-based standards, in the context of public health. We describe these evaluation tools, how they are used, their shortcomings, and how they should be interpreted. As with other powerful tools, they are subject to misuse and misinterpretation, even by profe...

Formal analyses can be valuable aids to decision-making if their limits are understood. Those limits arise from the two forms of subjectivity found in all analyses: ethical judgments, made when setting the terms of an analysis, and scientific judgments, made when conducting it. As formal analysis has assumed a larger role in policy decisions, awareness of those judgments has grown, as have meth...

Cost-benefit analysis (CBA) evaluates actions in terms of negative consequences (costs) and positive consequences (benefits). Though much has been said on CBA, little attention has been paid to the types of values held by costs and benefits. This paper introduces a simple typology of values in CBA and applies it to three forms of CBA: the common, money-based CBA, CBA based in social welfare, an...

BACKGROUND Helicobacter pylori screening may markedly reduce mortality and morbidity in the decades ahead. AIMS This study explores the costs and benefits of population-based H. pylori screening in terms of health care cost taking into account all relevant H. pylori-related diseases. MATERIAL AND METHODS The computer-based decision analysis compared two strategies: (1) screen for H. pylori ...